Infectious Complications of Cancer

  • Jean Klastersky

Part of the Cancer Treatment and Research book series (CTAR, volume 79)

Table of contents

About this book


Despite the major developments in the therapeutic armamentarium for the treatment of infection, the morbidity and mortality of this complication remains very high in patients with compromised defences. Cancer and its treatment represents a major predisposing condition to a variety of infections. These adverse events are still with us, in spite of much progress in the therapy of infectious disease, since cancer therapy is becoming more aggressive, yet further lowering the host's capacity to cope with infections. Moreover, the pathogens adapt effectively to drugs, and at a pace that might outrun industry's capability to produce new agents. Finally, new pathogens are appearing as a consequence of both selection and severe immunosuppression.
Infection is so common among cancer patients that its diagnosis and management represent a daily challenge to all oncologists, who must continually strive to keep abreast of developments in the area. The present comprehensive review of the most crucial and challenging aspects of the infectious complications in cancer patients will help them to do just that.


bacteria bacterial infection bacterial infections fungal infection infection infection control infections infectious infectious disease

Editors and affiliations

  • Jean Klastersky
    • 1
  1. 1.Service de Medecine Interne et Laboratoire d’Inverstigation, Clinique, H.J. Tagnon, Institut Jules BordetCentre des Tumeurs de L’UniversiteLibre de BruxellesBelgium

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag US 1995
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4612-8527-4
  • Online ISBN 978-1-4613-1239-0
  • Series Print ISSN 0927-3042
  • Buy this book on publisher's site